AGP Picks
View all

SynovAI launches AI retrosynthesis app in Paramus

Jul. 2, 2026
By AI, Created 08:36 UTC, Jul 02, 2026, AGP -

SynovAI is now available inside Paramus’ chemistry operating system, giving scientists a way to run validated retrosynthesis planning alongside other chemistry tools. The integration is designed to speed route selection, improve reproducibility and keep sensitive research data under user control in local deployments.

Why it matters: - SynovAI adds route-planning software to Paramus’ chemistry OS, bringing AI retrosynthesis into a platform built for reproducible, verifiable chemistry workflows. - The integration targets medicinal chemistry, process development and other small-molecule programs, where faster route selection can shorten development cycles. - The combined workflow is designed to help teams compare options faster and avoid dead-end synthesis plans.

What happened: - SynovAI and Paramus announced that SynovAI is now available as an app on Paramus. - The release went out July 2, 2026. - SynovAI runs synthesis planning inside Paramus alongside quantum chemistry engines, molecular dynamics, knowledge graphs and laboratory automation. - The app is available now in the Paramus Science App Store.

The details: - SynovAI processes target molecules through a validated model and sorts through hundreds of candidate routes. - The system proposes synthetic pathways in seconds rather than hours. - Each route can be ranked by feasibility, cost and scalability. - Paramus is positioned as an MCP-native operating system for chemistry that is built so AI agents calculate rather than hallucinate. - Paramus unifies more than 100 apps and 2,000 chemistry skills. - The platform connects to AI assistants including Claude, Gemini and ChatGPT. - Paramus uses a dual-mode architecture that can run classical AI, large language models and heavy calculations locally or in the cloud. - Local deployment is intended to support reproducibility and IP safety. - Cloud deployment is intended to support team collaboration.

Between the lines: - The partnership reflects a broader push to make AI output in chemistry more inspectable and less dependent on trust. - For SynovAI, the Paramus app format extends route-planning tools into a broader chemistry workflow rather than leaving them as a standalone product. - For Paramus, adding SynovAI fills a specific gap in its app ecosystem with dedicated retrosynthesis capability. - Jessica Freeze, PhD, said retrosynthesis is one of the highest-value decisions in discovery programs aimed at commercialization and that SynovAI is meant to help teams reach an actionable pathway decision in seconds. - Thorsten Gressling said AI agents must emit provenance, not plausibility, and that synthesis routes must be inspectable and verifiable.

What's next: - SynovAI and Paramus say the integration is meant to help scientists move from target molecule to route decision faster. - The companies said the combination aims to improve route selection while keeping sensitive research data under the user’s control in local deployments. - SynovAI is continuing to position its validated retrosynthesis engine as a tool for teams that want faster planning and more practical synthetic pathways.

The bottom line: - SynovAI’s move into Paramus turns retrosynthesis into a native chemistry workflow, with speed and verification pitched as the main value.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

World Healthcare Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

World Healthcare Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.